Market Place
Sourcing Support
Abbvie Unveils Topline Results for Epcoritamab Phase 3 Results
17 Jan 2026 //
PR NEWSWIRE
Abbvie`s Skyrizi Takes Full-Year TV Ad Spending Crown Yet Again
16 Jan 2026 //
FIERCE PHARMA
Abbvie Seeks Oncology Pipeline Respect Post Remegen Acquisition
14 Jan 2026 //
BIOSPACE
AbbVie Plans to Build Out Its Presence In Obesity Market
14 Jan 2026 //
REUTERS
AbbVie, Amgen, Lilly Urge FDA to Update Post-Approval Rules
13 Jan 2026 //
BIOSPACE
AbbVie, Trump Reach Agreement to Improve Access for Americans
12 Jan 2026 //
PRESS RELEASE
AbbVie to Acquire Arizona Manufacturing Facility
12 Jan 2026 //
PRESS RELEASE
AbbVie Pens $5.6B Pact with RemeGen to join PD-1xVEGF race
12 Jan 2026 //
PRESS RELEASE
Tempus Achieves Record Total Contract Value Exceeding $1.1 B
11 Jan 2026 //
BUSINESSWIRE
Xilio Therapeutics Highlights Upcoming Milestones
08 Jan 2026 //
GLOBENEWSWIRE
Alceus Bio Awarded Pioneer Group And Abbvie`s Golden Ticket
08 Jan 2026 //
PHARMIWEB
Abbvie Hosts 2025 Full-Year Earnings Conference Call
07 Jan 2026 //
PR NEWSWIRE
J&J`s Tremfya Closes Out 2025 As December`s Top TV Ad Spender
06 Jan 2026 //
FIERCE PHARMA
Abbvie Presents At 44Th J.P. Morgan Healthcare Conference
05 Jan 2026 //
PR NEWSWIRE
Zelgen, AbbVie Sign Up-to-$1.2B DLL3 T Cell Engager Deal
04 Jan 2026 //
FIRSTWORDPHARMA
Abbvie, Gilead Gift Themselves Clinical-Stage Cancer Drugs
02 Jan 2026 //
FIERCE BIOTECH
Redhill Bio Opaganib Shows Promise In Venetoclax-Resistant Cells
15 Dec 2025 //
PR NEWSWIRE
OSE Immuno Announces Strategic Amendment to AbbVie
09 Dec 2025 //
GLOBENEWSWIRE
Abbvie Revs Up Skyrizi Spending To Top TV Ad Totals In November
05 Dec 2025 //
FIERCE PHARMA
Abbvie To Present Latest Advances In Blood Cancer Treatments
02 Dec 2025 //
PR NEWSWIRE
AbbVie at ASH 2025 New Blood Cancer Data Across Modalities
02 Dec 2025 //
PRESS RELEASE
AbbVie Data Shows Atogepant Superior to Placebo
01 Dec 2025 //
PRESS RELEASE
Abbvie Concludes Loi With Pan-Canadian Pharma Alliance
28 Nov 2025 //
GLOBENEWSWIRE
Abbvie, Admare Bioinnovations Launch Abbvie Biotech Innovators
26 Nov 2025 //
GLOBENEWSWIRE
Biomed X Launches Neuroscience Research Partnership In US
25 Nov 2025 //
PHARMIWEB
Abbvie, Admare Bioinnovations Launch Abbvie Biotech Innovators
25 Nov 2025 //
GLOBENEWSWIRE
AbbVie film showcases ‘Second Winds’ of life after CLL diagnosis
25 Nov 2025 //
FIERCE PHARMA
Abbvie To Present At Piper Sandler Healthcare Conference
24 Nov 2025 //
PR NEWSWIRE
AbbVie Announces US FDA Approval of Epkinly
19 Nov 2025 //
PRESS RELEASE
Abbvie To End Calico Collab, Lay Off Scientists
12 Nov 2025 //
FIERCE BIOTECH
Record Earnings For Gubra; Revised Outlook For The CRO Business
06 Nov 2025 //
PHARMIWEB
Calico Gets FDA Orphan Tag For ADPKD Investigational Drug
05 Nov 2025 //
PR NEWSWIRE
Abbvie Reports Third-Quarter 2025 Financial Results
31 Oct 2025 //
PRESS RELEASE
Botox Cosmetic Day Marks Biggest Annual Celebration on November
30 Oct 2025 //
PR NEWSWIRE
Abbvie Reports Upadacitinib Success In Vitiligo Ph3 Trials
29 Oct 2025 //
PRESS RELEASE
Abbvie Halts Development Of Dragonfly Cancer Asset In Midflight
29 Oct 2025 //
FIERCE BIOTECH
Zag Bio Emerges With $80M Funding For Tregs Diabetes Candidate
28 Oct 2025 //
FIERCE BIOTECH
Abbvie`s Rinvoq Beats Humira In Key Arthritis Trial
22 Oct 2025 //
INDPHARMAPOST
BOTOX® Cosmetic`s Confidence Project Reveals Grant Recipients
21 Oct 2025 //
PR NEWSWIRE
Upadacitinib Outperforms Adalimumab In Rheumatoid Arthritis Study
20 Oct 2025 //
PR NEWSWIRE
AbbVie Completes Acquisition of Gilgamesh Pharma` Bretisilocin
17 Oct 2025 //
PR NEWSWIRE
Enveric Bio Hires IP Firm to Defend Patent Linked to AbbVie Deal
15 Oct 2025 //
PHARMIWEB
FDA Approves Abbvie`s Upadacitinib For Inflammatory Bowel Disease
14 Oct 2025 //
PRESS RELEASE
Abbvie Presents ADC Data For Hard-To-Treat Cancers At ESMO 2025
14 Oct 2025 //
INDPHARMAPOST
Abbvie Showcases Solid Tumor Targeted Therapy Leadership At ESMO
13 Oct 2025 //
PR NEWSWIRE
Allergan Aesthetics Launches Skinmedica`s Reimagined Packaging
11 Oct 2025 //
INDPHARMAPOST
Abbvie Taps Tyler James Williams For New IBD Campaign
07 Oct 2025 //
FIERCE PHARMA
AbbVie Reports Positive Ph2 ELATE Data for Botox in Tremor
06 Oct 2025 //
PRESS RELEASE
Abbvie Cuts Annual Profit Forecast Due To Anticipated $2.7B R&D
03 Oct 2025 //
REUTERS
Calico Gets FDA Fast Track for ADPKD Investigational Treatment
02 Oct 2025 //
PR NEWSWIRE
Abbvie, Beone End BTK Inhibitor Patent Fight
02 Oct 2025 //
FIERCE PHARMA
Natrelle® Awarded Supplier Agreement From Vizient
01 Oct 2025 //
PR NEWSWIRE
Abbvie Commences $70m Biologics Manufacturing Site Construction
01 Oct 2025 //
FIERCE PHARMA
Bms, Takeda Join Peers In Push To Improve AI By Pooling Data
01 Oct 2025 //
FIERCE BIOTECH
Abbvie Files BLA For Pivekimab Sunirine To Treat Rare Cancer
30 Sep 2025 //
PR NEWSWIRE
AbbVie Breaks Ground on Chicago API Manufacturing Plant
30 Sep 2025 //
PRESS RELEASE
Nxera Pharma To Get $10M Milestone Payment From Abbvie
29 Sep 2025 //
GLOBENEWSWIRE
Abbvie Files Tavapadon NDA With US FDA For Parkinson`s Disease
26 Sep 2025 //
PR NEWSWIRE
Arcturus Sues AbbVie Over Drug-Delivery Trade Secrets
24 Sep 2025 //
REUTERS
Abbvie Enters Psychedelics Space, Signaling New Era
22 Sep 2025 //
BIOSPACE
